How Are You Testing Your NASH Patients?

Dr. Arun Sanyal
Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health

Virginia Commonwealth University

|01.07.22

In this 5-minute video, Dr. Sanyal discusses why risk-stratification of patients with advanced fibrosis due to NASH is so important and how he anticipates using the Enhanced Liver Fibrosis (ELF™) Test  Enhanced Liver Fibrosis (ELF™) Test in his clinical practice.